MedCap AB (publ) logo

MedCap AB (publ) (61MA)

Market Closed
10 Aug, 20:00
XFRA XFRA
48. 26
+0.44
+0.9201%
669.64M Market Cap
- P/E Ratio
- Div Yield
40 Volume
- Eps
47.82
Previous Close
Add Transaction
Day Range
48.26 48.26
Year Range
41.2 59.3
Want to track 61MA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

61MA closed today higher at €48.26, an increase of 0.9201% from yesterday's close, completing a monthly increase of 2.8121% or €1.32. Over the past 12 months, 61MA stock lost -4.0557%.
61MA is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.4667%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

61MA Chart

People also search for

Zai Lab Limited
1.93
-0.5155%
Ping An Healthcare and Technology Company Limited ADR
1.44
+2.8571%
Ryman Healthcare Limited Unsponsored ADR
4.9
+0.4098%
2LS
Siloam International Hospitals Tbk.
0.1
0%
Konica Minolta Inc.
3.53
-0.8991%

MedCap AB (publ) (61MA) FAQ

What is the stock price today?

The current price is €48.26.

On which exchange is it traded?

MedCap AB (publ) is listed on XFRA.

What is its stock symbol?

The ticker symbol is 61MA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 669.64M.

Has MedCap AB (publ) ever had a stock split?

No, there has never been a stock split.

MedCap AB (publ) Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
XFRA Exchange
SE0009160872 ISIN
Sweden Country
534 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

MedCap AB (publ) is a distinguished private equity firm with a focused expertise in the healthcare and life sciences sectors. Founded in 2001, the firm is headquartered in Stockholm, Sweden, and operates primarily within the Nordic region and Northern Europe. MedCap specializes in a variety of investment stages including secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. The firm’s investment strategy is particularly tailored towards small to medium-sized companies that are privately held, aiming to provide capital for growth and development in a sector that is critical to the advancement of medical and healthcare technologies and services.

Products and Services

MedCap AB offers a diversified portfolio of investment products and services designed to target the unique opportunities within the healthcare sector:

  • Secondary Direct Investments: MedCap engages in direct transactions to acquire stakes in promising healthcare and life sciences companies, facilitating liquidity to existing investors or shareholders without the necessity for an initial public offering.
  • Later Stage Investments: Targeting companies that have surpassed the developmental phase and have established market presence, MedCap provides the necessary capital to scale operations, expand market reach, or enhance product offerings.
  • Industry Consolidation: MedCap identifies opportunities to bolster industry stability and growth potential by supporting strategic mergers and acquisitions, aiming to create synergy and enhance competitiveness in the healthcare market.
  • Add-on Acquisitions: For its portfolio companies, MedCap seeks add-on acquisitions that can complement existing operations, extend market coverage, or introduce novel technologies and services to the business model.
  • Growth Capital: Offering growth capital for expansion or operational improvement projects, MedCap assists companies in reaching their next developmental stage while supporting innovation in healthcare technologies and services.
  • Middle Market Investments: Focused on companies with stable revenue models and potential for robust growth, MedCap’s middle market investments encourage strategic development and market expansion.
  • Mature Company Investments: Recognizing the value in well-established companies, MedCap invests in mature enterprises seeking capital for restructuring, operational improvements, or market expansion strategies.
  • Turnaround Investments: Specializing in turnarounds, MedCap provides strategic, operational, and financial restructuring support to companies facing challenging periods, aiming to revitalize their business operations.
  • Buyout: MedCap participates in buyout transactions, acquiring majority or significant minority stakes in companies, guiding them toward achieving long-term growth and operational excellence.

Contact Information

Address: Engelbrektsgatan 9-11
Phone: 46 8 34 71 10